{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:23:36Z","timestamp":1793593416564,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jogc.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T14:22:59Z","timestamp":1628691779000},"page":"1188-1204.e1","source":"Crossref","is-referenced-by-count":44,"title":["Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle"],"prefix":"10.1016","volume":"43","author":[{"given":"Nese","family":"Yuksel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Evaniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unjali","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Wolfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2021.08.003_bib0001","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/13697137.2017.1306507","article-title":"The menopausal hot flush: A review","volume":"20","author":"Sturdee","year":"2017","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0002","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ogc.2011.05.006","article-title":"Vasomotor symptoms and menopause: Findings from the study of women's health across the nation","volume":"38","author":"Thurston","year":"2011","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.jogc.2021.08.003_bib0003","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/gme.0b013e31815879cf","article-title":"Abdominal adiposity and hot flashes among midlife women","volume":"15","author":"Thurston","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0004","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/13697130601181486","article-title":"Prevalence of hot flushes and night sweats around the world: A systematic review","volume":"10","author":"Freeman","year":"2007","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/13697137.2011.608596","article-title":"Menopausal hot flushes and night sweats: Where are we now?","volume":"14","author":"Archer","year":"2011","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0006","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jogc.2021.08.003_bib0007","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/GME.0000000000000676","article-title":"Characterizing the trajectories of vasomotor symptoms across the menopausal transition","volume":"23","author":"Tepper","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0008","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2005-869479","article-title":"Pathophysiology and treatment of menopausal hot flashes","volume":"23","author":"Freedman","year":"2005","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.jogc.2021.08.003_bib0009","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000495889","article-title":"Neurokinin 3 receptor antagonism: A novel treatment for menopausal hot flushes","volume":"109","author":"Modi","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jogc.2021.08.003_bib0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/GME.0000000000001530","article-title":"More promising news (mostly) on manipulating neurokinin b activity as a nonhormonal treatment of hot flashes","volume":"27","author":"Reame","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0011","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/GME.0000000000001144","article-title":"Neurokinin 3 receptor antagonists for treatment of vasomotor symptoms: A new panacea or just a flash in the pan?","volume":"25","author":"Faubion","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0012","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/GME.0000000000001500","article-title":"Effects of nt-814, a dual neurokinin 1 and 3 receptor antagonist, on vasomotor symptoms in postmenopausal women: A placebo-controlled, randomized trial","volume":"27","author":"Trower","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0013","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/13697137.2018.1430131","article-title":"Vasomotor symptoms: Natural history, physiology, and links with cardiovascular health","volume":"21","author":"Thurston","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0014","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1161\/STROKEAHA.116.014674","article-title":"Menopausal hot flashes and carotid intima media thickness among midlife women","volume":"47","author":"Thurston","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jogc.2021.08.003_bib0015","article-title":"Menopausal symptoms: Comparative effectiveness of therapies. Ahrq comparative effectiveness reviews","author":"Grant","year":"2015","journal-title":"Rockville (MD)"},{"key":"10.1016\/j.jogc.2021.08.003_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002978.pub2","article-title":"Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes","author":"Maclennan","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2021.08.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002229.pub4","article-title":"Hormone therapy for preventing cardiovascular disease in post-menopausal women","author":"Boardman","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2021.08.003_bib0018","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the women's health initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2021.08.003_bib0019","article-title":"Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women","volume":"122","author":"Salpeter","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.jogc.2021.08.003_bib0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0015-0282(16)53513-4","article-title":"Clinical features of young women with hypergonadotropic amenorrhea","volume":"53","author":"Rebar","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2021.08.003_bib0021","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/gme.0b013e318247f07a","article-title":"Oral micronized progesterone for vasomotor symptoms\u2013a placebo-controlled randomized trial in healthy postmenopausal women","volume":"19","author":"Hitchcock","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0022","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.1980.03310130021021","article-title":"Oral medroxyprogesterone in the treatment of postmenopausal symptoms","volume":"244","author":"Schiff","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2021.08.003_bib0023","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/GME.0000000000000175","article-title":"Extended duration use of menopausal hormone therapy","volume":"21","author":"Kaunitz","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0024","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/GME.0000000000000492","article-title":"The North American Menopause Society statement on continuing use of systemic hormone therapy after age 65","volume":"22","year":"2015","journal-title":"Menopause."},{"key":"10.1016\/j.jogc.2021.08.003_bib0025","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.mayocp.2016.08.002","article-title":"Accelerated accumulation of multimorbidity after bilateral oophorectomy: A population-based cohort study","volume":"91","author":"Rocca","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jogc.2021.08.003_bib0026","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","article-title":"Increased cardiovascular mortality after early bilateral oophorectomy","volume":"16","author":"Rivera","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0027","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jogc.2021.08.003_bib0028","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/gme.0b013e31823e9b2e","article-title":"Long-term impacts of early and surgical menopause","volume":"19","author":"Hunter","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0029","first-page":"370","article-title":"Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: A randomized prospective study","volume":"13","author":"Haimov-Kochman","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/gme.0b013e3181b397c7","article-title":"A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms","volume":"17","author":"Lindh-Astrand","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0032","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/13697137.2016.1187123","article-title":"The impact of micronized progesterone on the endometrium: A systematic review","volume":"19","author":"Stute","year":"2016","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0033","first-page":"539","article-title":"Effects of various types and dosages of progestogens on the postmenopausal endometrium","volume":"27","author":"Whitehead","year":"1982","journal-title":"J Reprod Med"},{"key":"10.1016\/j.jogc.2021.08.003_bib0031","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0029-7844(95)00115-8","article-title":"Combined continuous hormone replacement therapy: A critical review","volume":"86","author":"Udoff","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0034a","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2021.08.003_bib0035","series-title":"Menopause: Diagnosis and management","year":"2015"},{"key":"10.1016\/j.jogc.2021.08.003_bib0036","unstructured":"Menopause practice: A clinician's guide, 6th ed. The North American Menopause Society. Available at http:\/\/www.menopause.org\/publications\/professional-publications\/em-menopause-practice-em-textbook. Accessed: August 4, 2021."},{"key":"10.1016\/j.jogc.2021.08.003_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2021.09.010","article-title":"Guideline no. 422e: Menopause and cardiovascular disease","volume":"43","author":"Abramson","year":"2021","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2021.08.003_bib0038","series-title":"Goodman & gilman's: The pharmacological basis of therapeutics, 13e","article-title":"Chapter 44: Estrogens, progestins, and the female reproductive tract","author":"Levin","year":"2017"},{"key":"10.1016\/j.jogc.2021.08.003_bib0039","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: Results from the E3N cohort study","volume":"30","author":"Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/humupd\/dmy039","article-title":"The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: A systematic review","volume":"25","author":"Oliver-Williams","year":"2019","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.jogc.2021.08.003_bib0041","doi-asserted-by":"crossref","first-page":"k4810","DOI":"10.1136\/bmj.k4810","article-title":"Use of hormone replacement therapy and risk of venous thromboembolism: Nested case-control studies using the qresearch and cprd databases","volume":"364","author":"Vinogradova","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2021.08.003_bib0042","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/13697137.2014.991302","article-title":"The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: A clinical review","volume":"18","author":"Depypere","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0043","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile","volume":"92","author":"Lobo","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2021.08.003_bib0044","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/gme.0b013e3181a7df0d","article-title":"Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene\/conjugated estrogens: A randomized, controlled trial","volume":"16","author":"Pinkerton","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/GME.0b013e318271f5e7","article-title":"Breast density changes in a randomized controlled trial evaluating bazedoxifene\/conjugated estrogens","volume":"20","author":"Harvey","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0046","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31828c5974","article-title":"Breast effects of bazedoxifene-conjugated estrogens: A randomized controlled trial","volume":"121","author":"Pinkerton","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0047","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1517\/13543784.2010.532487","article-title":"Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women","volume":"19","author":"Pinkerton","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jogc.2021.08.003_bib0048","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/13697137.2012.717994","article-title":"Effects of bazedoxifene\/conjugated estrogens on endometrial safety and bone in postmenopausal women","volume":"16","author":"Mirkin","year":"2013","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0049","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1210\/jc.2013-1707","article-title":"Effects of bazedoxifene\/conjugated estrogens on the endometrium and bone: A randomized trial","volume":"99","author":"Pinkerton","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jogc.2021.08.003_bib0050","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3109\/09513590.2010.495437","article-title":"Tibolone in postmenopausal women: A review based on recent randomised controlled clinical trials","volume":"26","author":"Biglia","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0051","article-title":"Short-term and long-term effects of tibolone in postmenopausal women","volume":"10","author":"Formoso","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2021.08.003_bib0052","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","article-title":"Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: A double-blind, randomised, non-inferiority trial","volume":"10","author":"Kenemans","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0053","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1067\/mob.2002.121896","article-title":"Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density","volume":"186","author":"Lundstrom","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0054","unstructured":"Tibella product monograph [June 2020]. Available at https:\/\/pdf.hres.ca\/dpd_pm\/00051104.PDF. Accessed: August 4, 2021."},{"key":"10.1016\/j.jogc.2021.08.003_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2021.09.001","article-title":"Guideline no. 422b: Menopause and genitourinary health","volume":"43","author":"Johnston","year":"2021","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2021.08.003_bib0056","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/GME.0000000000000428","article-title":"Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)","volume":"22","author":"Archer","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0057","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.maturitas.2015.02.005","article-title":"Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study","volume":"81","author":"Labrie","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.jogc.2021.08.003_bib0058","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/GME.0000000000000571","article-title":"Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause","volume":"23","author":"Labrie","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0059","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/GME.0000000000000470","article-title":"Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women","volume":"22","author":"Portman","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0060","unstructured":"Intrarosa product monograph [June 2020]. Available at https:\/\/fernandlabrie.blob.core.windows.net\/media\/5025\/non-annotated-pm-word_approved.pdf. Accessed: August 4, 2021."},{"key":"10.1016\/j.jogc.2021.08.003_bib0061","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/GME.0000000000001292","article-title":"Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: A phase 3, randomized, double-blind, placebo-controlled, multicenter trial","volume":"26","author":"Archer","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0062","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/gme.0b013e3181c1ac01","article-title":"Ospemifene Study G. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: Results from a pivotal phase 3 study","volume":"17","author":"Bachmann","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0063","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/gme.0b013e318279ba64","article-title":"Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy","volume":"20","author":"Portman","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0064","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/13697137.2013.834493","article-title":"Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy","volume":"17","author":"Goldstein","year":"2014","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.maturitas.2018.11.017","article-title":"Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part ii: Evaluation of tolerability and safety","volume":"121","author":"Di Donato","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/j.jogc.2021.08.003_bib0066","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/jwh.2017.6385","article-title":"Overall safety of ospemifene in postmenopausal women from placebo-controlled phase 2 and 3 trials","volume":"27","author":"Simon","year":"2018","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jogc.2021.08.003_bib0067","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.maturitas.2020.06.021","article-title":"No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (vva)","volume":"142","author":"Cai","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.jogc.2021.08.003_bib0068","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/GME.0000000000001215","article-title":"Continuation of postmenopausal hormone replacement therapy: Comparison of cyclic versus continuous combined schedules","volume":"25","author":"Ettinger","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0069","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/GRF.0000000000000364","article-title":"Differential effects of progestogens used for menopausal hormone therapy","volume":"61","author":"Van Heertum","year":"2018","journal-title":"Clin Obstet Gynecol"},{"issue":"Suppl 3","key":"10.1016\/j.jogc.2021.08.003_bib0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/humrep\/15.suppl_3.7","article-title":"Disturbances of endometrial bleeding with hormone replacement therapy","volume":"15","author":"Thomas","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2021.08.003_bib0071","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3109\/13697137.2010.490605","article-title":"Transdermal estradiol and oral or vaginal natural progesterone: Bleeding patterns","volume":"13","author":"Di Carlo","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0072","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4321\/S1886-36552011000100003","article-title":"Defining bioidentical hormones for menopause-related symptoms","volume":"9","author":"Whelan","year":"2011","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.jogc.2021.08.003_bib0073","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/GME.0000000000000901","article-title":"Promotion and marketing of bioidentical hormone therapy on the internet: A content analysis of websites","volume":"24","author":"Yuksel","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0074","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/GCO.0b013e3283081ae9","article-title":"Bioidentical hormone therapy: A panacea that lacks supportive evidence","volume":"20","author":"Boothby","year":"2008","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0075","series-title":"The clinical utility of compounded bioidentical hormone therapy: A review of safety, effectiveness, and use","article-title":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Replacement Therapy","year":"2020"},{"key":"10.1016\/j.jogc.2021.08.003_bib0076","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004923.pub2","article-title":"Non-hormonal interventions for hot flushes in women with a history of breast cancer","author":"Rada","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2021.08.003_bib0077","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: Systematic review and meta-analysis","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2021.08.003_bib0078","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1177\/0269881108093582","article-title":"Problems associated with long-term treatment with selective serotonin reuptake inhibitors","volume":"23","author":"Moret","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0079","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/13697137.2012.655923","article-title":"Quality of life and the role of menopausal hormone therapy","volume":"15","author":"Pines","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/11585360-000000000-00000","article-title":"Non-hormonal treatment strategies for vasomotor symptoms: A critical review","volume":"71","author":"Hall","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.jogc.2021.08.003_bib0081","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/GME.0b013e3182a66aa7","article-title":"Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: Two randomized controlled trials","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0082","first-page":"77","article-title":"Paroxetine-the antidepressant from hell? Probably not, but caution required","volume":"46","author":"Nevels","year":"2016","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.jogc.2021.08.003_bib0083","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv337","article-title":"Tamoxifen and antidepressant drug interaction in a cohort of 16,887 breast cancer survivors","volume":"108","author":"Haque","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jogc.2021.08.003_bib0084","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1592\/phco.29.1.74","article-title":"Use of gabapentin in patients experiencing hot flashes","volume":"29","author":"Brown","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jogc.2021.08.003_bib0085","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1345\/aph.1P366","article-title":"Use of gabapentin for the management of natural or surgical menopausal hot flashes","volume":"45","author":"Hayes","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jogc.2021.08.003_bib0086","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1200\/JCO.2009.24.5647","article-title":"Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, n07c1","volume":"28","author":"Loprinzi","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0087","series-title":"Health Canada advises canadians to exercise caution when taking gabapentin or pregabalin with opioids","year":"2019"},{"key":"10.1016\/j.jogc.2021.08.003_bib0088","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1097\/GME.0000000000000773","article-title":"Extended-release oxybutynin therapy for vasomotor symptoms in women: A randomized clinical trial","volume":"23","author":"Simon","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0089","doi-asserted-by":"crossref","first-page":"pkz088","DOI":"10.1093\/jncics\/pkz088","article-title":"Oxybutynin vs placebo for hot flashes in women with or without breast cancer: A randomized, double-blind clinical trial (accru sc-1603)","volume":"4","author":"Leon-Ferre","year":"2020","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.jogc.2021.08.003_bib0090","doi-asserted-by":"crossref","DOI":"10.1007\/s00192-021-04909-5","article-title":"A systematic review of neurocognitive dysfunction with overactive bladder medications","author":"Duong","year":"2021","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.jogc.2021.08.003_bib0091","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/gme.0b013e31813429d6","article-title":"Use of complementary and alternative medicine during the menopause transition: Longitudinal results from the study of women's health across the nation","volume":"15","author":"Bair","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0092","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/01.gme.0000179047.00748.53","article-title":"Us women desire greater professional guidance on hormone and alternative therapies for menopause symptom management","volume":"13","author":"Ma","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0093","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/1471-0528.15153","article-title":"Mindfulness, cognitive behavioural and behaviour-based therapy for natural and treatment-induced menopausal symptoms: A systematic review and meta-analysis","volume":"126","author":"van Driel","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.jogc.2021.08.003_bib0094","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/GME.0000000000001363","article-title":"Cognitive behavior therapy for menopausal symptoms (CBT-Meno): A randomized controlled trial","volume":"26","author":"Green","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0095","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/gme.0b013e31823fe835","article-title":"Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): A randomized controlled trial","volume":"19","author":"Ayers","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0096","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/GME.0000000000000297","article-title":"Beliefs about hot flashes drive treatment benefit","volume":"21","author":"Hunter","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0097","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2014.01.007","article-title":"Cognitive behaviour therapy for menopausal symptoms following breast cancer treatment: Who benefits and how does it work?","volume":"78","author":"Chilcot","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.jogc.2021.08.003_bib0098","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/S1352465812000677","article-title":"Cognitive behaviour therapy for menopausal hot flushes and night sweats: A qualitative analysis of women's experiences of group and self-help cbt","volume":"41","author":"Balabanovic","year":"2013","journal-title":"Behav Cogn Psychother"},{"key":"10.1016\/j.jogc.2021.08.003_bib0099","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1200\/JCO.2008.16.6389","article-title":"Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors","volume":"26","author":"Elkins","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/gme.0b013e31826ce3ed","article-title":"Clinical hypnosis in the treatment of postmenopausal hot flashes: A randomized controlled trial","volume":"20","author":"Elkins","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0101","unstructured":"Government of Canada. About natural health product regulation in Canada. Available at https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/natural-non-prescription\/regulation.html. Accessed December 1, 2019."},{"key":"10.1016\/j.jogc.2021.08.003_bib0102","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/GME.0000000000000546","article-title":"Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of the North American Menopause Society","volume":"22","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0103","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.GME.0000058147.24036.B0","article-title":"A systematic review of herbal medicinal products for the treatment of menopausal symptoms","volume":"10","author":"Huntley","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0104","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-137-10-200211190-00009","article-title":"Complementary and alternative medicine for menopausal symptoms: A review of randomized, controlled trials","volume":"137","author":"Kronenberg","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jogc.2021.08.003_bib0105","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001395.pub4","article-title":"Phytoestrogens for menopausal vasomotor symptoms","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2021.08.003_bib0106","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/jmf.2018.4265","article-title":"Equol decreases hot flashes in postmenopausal women: A systematic review and meta-analysis of randomized clinical trials","volume":"22","author":"Daily","year":"2019","journal-title":"J Med Food"},{"key":"10.1016\/j.jogc.2021.08.003_bib0107","unstructured":"Government of Canada. Canada's food guide. Available at https:\/\/food-guide.canada.ca\/en\/. Accessed: August 4, 2021."},{"key":"10.1016\/j.jogc.2021.08.003_bib0108","unstructured":"Dietitians of Canada. Female nutrition Available at https:\/\/www.dietitians.ca\/Dietitians-Views\/Specific-Populations\/Female-Nutrition.aspx. Accessed June 1, 2020."},{"key":"10.1016\/j.jogc.2021.08.003_bib0109","doi-asserted-by":"crossref","DOI":"10.1016\/j.jogc.2016.01.001","article-title":"Canadian consensus on female nutrition: Adolescence, reproduction, menopause, and beyond","volume":"38","author":"O'Connor","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2021.08.003_bib0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-0036-1584582","article-title":"Sedentary lifestyle and high-carbohydrate intake are associated with low-grade chronic inflammation in post-menopause: A cross-sectional study","volume":"38","author":"Alves","year":"2016","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.jogc.2021.08.003_bib0111","doi-asserted-by":"crossref","DOI":"10.3390\/nu9121331","article-title":"Dietary factors and female breast cancer risk: A prospective cohort study","volume":"9","author":"Kim","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jogc.2021.08.003_bib0112","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/bjc.2016.98","article-title":"Association between dietary inflammatory potential and breast cancer incidence and death: Results from the women's health initiative","volume":"114","author":"Tabung","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jogc.2021.08.003_bib0113","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2337\/dc17-0534","article-title":"A low-fat dietary pattern and diabetes: A secondary analysis from the women's health initiative dietary modification trial","volume":"41","author":"Howard","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jogc.2021.08.003_bib0114","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1200\/JCO.2016.72.0326","article-title":"Low-fat dietary pattern and breast cancer mortality in the women's health initiative randomized controlled trial","volume":"35","author":"Chlebowski","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0115","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3945\/ajcn.115.110213","article-title":"Dietary patterns: From nutritional epidemiologic analysis to national guidelines","volume":"101","author":"Cespedes","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jogc.2021.08.003_bib0116","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3945\/ajcn.117.153270","article-title":"Low-fat dietary pattern and cardiovascular disease: Results from the women's health initiative randomized controlled trial","volume":"106","author":"Prentice","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jogc.2021.08.003_bib0117","series-title":"Sodium in Canada","year":"2017"},{"key":"10.1016\/j.jogc.2021.08.003_bib0118","doi-asserted-by":"crossref","DOI":"10.3390\/nu9050511","article-title":"Vegetable and fruit intake and fracture-related hospitalisations: A prospective study of older women","volume":"9","author":"Blekkenhorst","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.jogc.2021.08.003_bib0119","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s12603-015-0544-6","article-title":"Associations of protein intake and protein source with bone mineral density and fracture risk: A population-based cohort study","volume":"19","author":"Langsetmo","year":"2015","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.jogc.2021.08.003_bib0120","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3945\/ajcn.114.103846","article-title":"High glycemic index diet as a risk factor for depression: Analyses from the women's health initiative","volume":"102","author":"Gangwisch","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jogc.2021.08.003_bib0121","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3945\/jn.115.227900","article-title":"Greater adherence to the alternative healthy eating index is associated with lower incidence of physical function impairment in the nurses' health study","volume":"146","author":"Hagan","year":"2016","journal-title":"J Nutr"},{"key":"10.1016\/j.jogc.2021.08.003_bib0122","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5604\/12321966.1141391","article-title":"Are cognitive functions in post-menopausal women related with the contents of macro- and micro-components in the diet?","volume":"22","author":"Bojar","year":"2015","journal-title":"Ann Agric Environ Med"},{"key":"10.1016\/j.jogc.2021.08.003_bib0123","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s00394-017-1558-0","article-title":"Decreased lipogenesis-promoting factors in adipose tissue in postmenopausal women with overweight on a paleolithic-type diet","volume":"57","author":"Blomquist","year":"2018","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jogc.2021.08.003_bib0124","unstructured":"Food and Agriculture Organization of the United Nations. Food-based dietary guidelines - brazil. Available at http:\/\/www.fao.org\/nutrition\/education\/food-based-dietary-guidelines\/regions\/countries\/brazil\/en\/. Accessed June 1, 2020."},{"key":"10.1016\/j.jogc.2021.08.003_bib0125","first-page":"6","article-title":"Menopausal hot flashes: A concise review","volume":"10","author":"Bansal","year":"2019","journal-title":"J Midlife Health"},{"key":"10.1016\/j.jogc.2021.08.003_bib0126","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006108.pub4","article-title":"Exercise for vasomotor menopausal symptoms","author":"Daley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2021.08.003_bib0127","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/GME.0b013e31829e4baa","article-title":"Efficacy of yoga for vasomotor symptoms: A randomized controlled trial","volume":"21","author":"Newton","year":"2014","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0128","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/863905","article-title":"Effectiveness of yoga for menopausal symptoms: A systematic review and meta-analysis of randomized controlled trials","volume":"2012","author":"Cramer","year":"2012","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jogc.2021.08.003_bib0129","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archinternmed.2010.162","article-title":"An intensive behavioral weight loss intervention and hot flushes in women","volume":"170","author":"Huang","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jogc.2021.08.003_bib0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/GME.0000000000000274","article-title":"Behavioral weight loss for the management of menopausal hot flashes: A pilot study","volume":"22","author":"Thurston","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0131","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/gme.0b013e318204a05c","article-title":"Mindfulness training for coping with hot flashes: Results of a randomized trial","volume":"18","author":"Carmody","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0132","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/GME.0b013e31826934b6","article-title":"Paced breathing compared with usual breathing for hot flashes","volume":"20","author":"Sood","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0133","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/gme.0b013e318272ce80","article-title":"Effects of applied relaxation on vasomotor symptoms in postmenopausal women: A randomized controlled trial","volume":"20","author":"Lindh-Astrand","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0134","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007410.pub2","article-title":"Acupuncture for menopausal hot flushes","author":"Dodin","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2021.08.003_bib0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/13697137.2014.966241","article-title":"Efficacy of phytoestrogens for menopausal symptoms: A meta-analysis and systematic review","volume":"18","author":"Chen","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0136","first-page":"123","article-title":"Efficacy and safety of standard versus low-dose femarelle (dt56a) for the treatment of menopausal symptoms","volume":"31","author":"Yoles","year":"2004","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.jogc.2021.08.003_bib0137","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/13697137.2018.1501673","article-title":"Effects of red clover on perimenopausal and postmenopausal women's blood lipid profile: A meta-analysis","volume":"21","author":"Luis","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0138","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/gme.0b013e31817062ce","article-title":"Red clover extract: A putative source for simultaneous treatment of menopausal disorders and the metabolic syndrome","volume":"15","author":"Mueller","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0139","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/GME.0b013e3182896ae5","article-title":"Controlled flax interventions for the improvement of menopausal symptoms and postmenopausal bone health: A systematic review","volume":"20","author":"Dew","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0140","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007244.pub2","article-title":"Black cohosh (Cimicifuga spp.) for menopausal symptoms","author":"Leach","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2021.08.003_bib0141","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3797\/scipharm.1011-13","article-title":"Crinum latifolium leave extracts suppress immune activation cascades in peripheral blood mononuclear cells and proliferation of prostate tumor cells","volume":"79","author":"Jenny","year":"2011","journal-title":"Sci Pharm"},{"key":"10.1016\/j.jogc.2021.08.003_bib0142","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0015-0282(97)00397-X","article-title":"Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial","volume":"68","author":"Hirata","year":"1997","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jogc.2021.08.003_bib0143","doi-asserted-by":"crossref","DOI":"10.1177\/2515690X19829380","article-title":"Complementary and alternative medicine for menopause","volume":"24","author":"Johnson","year":"2019","journal-title":"J Evid Based Integr Med"},{"key":"10.1016\/j.jogc.2021.08.003_bib0144","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5142\/jgr.2013.37.30","article-title":"Ginseng for managing menopause symptoms: A systematic review of randomized clinical trials","volume":"37","author":"Kim","year":"2013","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.jogc.2021.08.003_bib0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/gme.0b013e3182325e4b","article-title":"Effects of red ginseng supplementation on menopausal symptoms and cardiovascular risk factors in postmenopausal women: A double-blind randomized controlled trial","volume":"19","author":"Kim","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0146","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/gme.0b013e31824017bc","article-title":"The pollen extract femal\u2013a nonestrogenic alternative to hormone therapy in women with menopausal symptoms","volume":"19","author":"Hellstrom","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.jogc.2021.08.003_bib0147","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13697130500117987","article-title":"Femal, a herbal remedy made from pollen extracts, reduces hot flushes and improves quality of life in menopausal women: A randomized, placebo-controlled, parallel study","volume":"8","author":"Winther","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.jogc.2021.08.003_bib0148","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.phymed.2010.01.007","article-title":"A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts","volume":"17","author":"Erkkola","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jogc.2021.08.003_bib0149","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.maturitas.2005.10.005","article-title":"A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts","volume":"54","author":"Heyerick","year":"2006","journal-title":"Maturitas"},{"key":"10.1016\/j.jogc.2021.08.003_bib0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.maturitas.2011.07.017","article-title":"Maca (lepidium meyenii) for treatment of menopausal symptoms: A systematic review","volume":"70","author":"Lee","year":"2011","journal-title":"Maturitas"}],"updated-by":[{"DOI":"10.1016\/j.jogc.2021.12.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000}}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216321006034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216321006034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T05:22:57Z","timestamp":1640323377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216321006034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":150,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1701216321006034"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2021.08.003","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}